{
    "eid": "2-s2.0-85147365199",
    "title": "Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "immunotherapy",
        "nasopharyngeal cancer",
        "pembrolizumab",
        "programmed death-1 (PD-1)"
    ],
    "authors": [
        "A. T.C. Chan",
        "V. H.F. Lee",
        "R. L. Hong",
        "M. J. Ahn",
        "W. Q. Chong",
        "S. B. Kim",
        "G. F. Ho",
        "P. B. Caguioa",
        "N. Ngamphaiboon",
        "C. Ho",
        "M. A.S.A. Aziz",
        "Q. S. Ng",
        "C. J. Yen",
        "N. Soparattanapaisarn",
        "R. K.C. Ngan",
        "S. K. Kho",
        "M. L.A. Tiambeng",
        "T. Yun",
        "V. Sriuranpong",
        "A. P. Algazi",
        "A. Cheng",
        "E. Massarelli",
        "R. F. Swaby",
        "S. Saraf",
        "J. Yuan",
        "L. L. Siu"
    ],
    "citedby-count": 6,
    "ref-count": 24,
    "ref-list": [
        "Nasopharyngeal carcinoma: an evolving paradigm",
        "Nasopharyngeal carcinoma",
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up",
        "Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives",
        "NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 1.2022. 2022",
        "Capecitabine maintenance therapy after induction chemotherapy in newly diagnosed metastatic nasopharyngeal carcinoma: an open-label, randomized, controlled, phase trial",
        "Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?",
        "EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy",
        "Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma",
        "Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study",
        "Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742)",
        "Efficacy, safety, and correlative biomarkers of toripalimab in previously treated recurrent or metastatic nasopharyngeal carcinoma: a phase II clinical trial (POLARIS-02)",
        "Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials",
        "Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial",
        "Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial",
        "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)",
        "Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer",
        "The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma",
        "The expanding universe of checkpoint inhibitors for nasopharyngeal cancer",
        "Phase II, randomized study of spartalizumab (PDR001), an anti-PD-1 antibody, versus chemotherapy in patients with recurrent/metastatic nasopharyngeal cancer",
        "An open-label, multicohort, phase I/II study to evaluate nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)",
        "The role of chemotherapy in the management of nasopharyngeal carcinoma",
        "Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kuching",
            "@id": "60090650",
            "affilname": "Hospital Umum Sarawak",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60073386",
            "affilname": "National Cheng Kung University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071488",
            "affilname": "University of Santo Tomas, Manila",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Goyang",
            "@id": "60068716",
            "affilname": "National Cancer Center, Gyeonggi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068716",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": null,
            "@id": "60024787",
            "affilname": "Prince of Wales Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60014234",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014234",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60013108",
            "affilname": "Princess Margaret Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013108",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60010400",
            "affilname": "Pantai Holdings Sdn Bhd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010400",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Vancouver",
            "@id": "60010365",
            "affilname": "The University of British Columbia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010365",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Duarte",
            "@id": "60007474",
            "affilname": "City of Hope National Med Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007474",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "127780700",
            "affilname": "National University Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127780700",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "San Juan City",
            "@id": "126186367",
            "affilname": "Cardinal Santos Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126186367",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "Merck Sharp & Dohme LLC"
    ]
}